Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma

Published:2020-03-18 Issue:4 Volume:14 Page:4816-4828
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yu Zhuo¹²,Guo Jianfeng¹³,Hu Mengying¹,Gao Yueqiu²,Huang Leaf¹^ORCID

Affiliation:

1. Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States

2. Department of Liver Disease, Shuguang Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

3. School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China

Funder

National Cancer Institute

China Scholarship Council

National Natural Science Foundation of China

Shanghai Rising-Star Program

Siming Scholar from Shanghai Shuguang Hospital

Talent Youth Supporting Project from Chinese Medicine Association

Shanghai Training Plan of Outstanding Young Medical Talents

Shanghai Chenguang Program

Talents Cultivation Program of Jilin University

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.0c00708

Reference42 articles.

1. Hepatocellular carcinoma

2. Characterization of the Immune Microenvironment in Hepatocellular Carcinoma

3. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment

4. Immune tolerance in liver disease

5. Chronic inflammation, immune escape, and oncogenesis in the liver: A unique neighborhood for novel intersections

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy;Biomaterials;2025-02

2. cGAS-STING activation by nanodelivery of teniposide achieves colorectal cancer chemo-immunotherapy;European Polymer Journal;2024-10

3. Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment;Future Pharmacology;2024-09-12

4. Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response;Journal of Medicinal Chemistry;2024-09-05

5. Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier‐Free Nanodrugs for Breast Cancer Immunotherapy;Advanced Healthcare Materials;2024-09-05